COMMUNIQUÉS West-GlobeNewswire

AB Science announces a slight delay in the publication of its 2025 half-year financial report
30/09/2025
PRESS RELEASE AB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2025 HALF-YEAR FINANCIAL REPORT THE COMPANY WILL PUBLISH ITS HALF-YEAR FINANCIAL REPORT FOR 2025 ON OCTOBER 10, 2025, AT THE LATEST Paris, [...]
Memorial Health Group Highlights 25 Years of Medical Excellence With Advanced Technology and Comprehensive Check-Up Programs
30/09/2025
Photo: Memorial Hospital Bahcelievler, Istanbul ISTANBUL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Memorial Health Group , one of Turkey’s largest private healthcare providers, is showcasing its combination of 25 years of [...]
Renouvellement complet du Conseil d'administration Élection du Dr Markus Cappel en tant que Président du Conseil d'administration
30/09/2025
Renouvellement complet du Conseil d'administration Élection du Dr Markus Cappel en tant que Président du Conseil d'administration NANTES, France, 30 septembre 2025, 19 heures 30 – OSE Immunotherapeutics SA (ISIN: [...]
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors
30/09/2025
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors Nantes, September 30, 2025, 7:30 p.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemonic: OSE) held its [...]
ROKIT America Accelerates Expansion in the Americas… Poised to Become a Strategic Hub for Reverse-Aging and Regenerative Medicine Platforms
30/09/2025
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ROKIT America, a U.S. subsidiary of AI-driven personalized organ regeneration platform specialist ROKIT Healthcare, is set to accelerate its business expansion across the [...]
SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)
30/09/2025
No safety concerns or dose limiting toxicities observed SCY-247 was able to achieve target exposures at doses lower than our first-generation fungerp Safety, tolerability, and pharmacokinetic profile support the [...]
Medera Strengthens Leadership Team with Three Key Executive Appointments
30/09/2025
Clinical operations, regulatory affairs, technical expertise, and corporate leadership additions support advancing gene therapy pipeline for cardiovascular diseases BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Medera Inc [...]
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
30/09/2025
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed study in Frontiers [...]
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
30/09/2025
BERKELEY, Calif. and MAINZ, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
30/09/2025
SARASOTA, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery [...]
STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis
30/09/2025
HORSHAM, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
FDA Clears OsteoProbe® (K250216): First-Ever Device Indication for Measuring Bone Material Strength
30/09/2025
SANTA BARBARA, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Active Life Scientific, Inc. (ALSI), a leader in innovative medical devices for bone quality, today announced that the U.S. Food and Drug Administration (FDA) [...]
Artelo Biosciences Announces Pricing of $2.0 Million Public Offering
30/09/2025
SOLANA BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
30/09/2025
CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression-Free Survival and Overall Survival FLORHAM PARK, N.J., Sept. 30, 2025 ( [...]
Cannabix Technologies Announces First Sale of BreathLogix Alcohol Screening Device to Maritime Market
30/09/2025
VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is [...]
Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial
30/09/2025
Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease Patients” [...]
Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market
30/09/2025
Revolutionary platform aims to make life-saving overdose reversal therapies more affordable, accessible, and effective worldwide VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy [...]
Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia
30/09/2025
BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update
30/09/2025
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for [...]

Pages